Analyst Activity – HC Wainwright Initiates Coverage On NASDAQ:BTAI – BioXcel Therapeutics (NASDAQ:BTAI) With a Buy

Analyst Ratings For NASDAQ:BTAI – BioXcel Therapeutics (NASDAQ:BTAI)

Story continues below

Today, HC Wainwright initiated coverage on NASDAQ:BTAI – BioXcel Therapeutics (NASDAQ:BTAI) with a Buy with a price target of $25.00.

Some recent analyst ratings include

  • 5/3/2018-HC Wainwright initiated coverage with a Buy rating.
  • 4/2/2018-Canaccord Genuity initiated coverage with a Buy rating.
  • 4/2/2018-BMO Capital Markets initiated coverage with a Outperform rating.
  • 4/2/2018-UBS initiated coverage with a Buy rating.
  • 4/2/2018-Barclays initiated coverage with a Overweight rating.


    Recent Trading Activity for NASDAQ:BTAI – BioXcel Therapeutics (NASDAQ:BTAI)
    Shares of NASDAQ:BTAI – BioXcel Therapeutics closed the previous trading session at 7.50 up +0.48 6.84% with 7.5 shares trading hands.

    An ad to help with our costs